View Pages
Data Governance for AI in Healthcare: US, China and Global Policy Impacts
Experts discuss how the US, China and other markets manage data governance, compute, and infrastructure to shape AI-driven bioscience innovation.
Editorial companion
What stands out
The event includes a Pfizer fireside chat on data governance for AI in healthcare — relevant for investors watching how regulatory and infrastructure debates intersect with Pfizer’s AI-enabled bioscience work. Use company commentary alongside the firm’s ratings to judge any claims.